Discontinuation of transmission-based precautions for patients with COVID-19: The decision to discontinue Transmission-Based Precautions should be made using a test-based strategy or a non-test-based strategy (i.e., time-since- illness-onset and time-since-recovery strategy). Meeting criteria for discontinuation of Transmission-Based Precautions is not a prerequisite for discharge.
Test-based strategy. Resolution of fever without the use of fever-reducing medications and Improvement in respiratory symptoms (e.g., cough, shortness of breath), and Negative results of an FDA Emergency Use Authorized COVID-19 molecular assay for detection of SARS-CoV-2 RNA from at least two consecutive nasopharyngeal swab specimens collected ≥24 hours apart (total of two negative specimens) [1]. See Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for 2019 Novel Coronavirus (2019-nCoV). Non-test-based strategy. At least 3 days (72 hours) have passed since recovery defined as resolution of fever without the use of fever-reducing medications and improvement in respiratory symptoms (e.g., cough, shortness of breath); and, At least 7 days have passed since symptoms first appeared When a Testing-Based Strategy is Preferred
Hospitalized patients may have longer periods of SARS-CoV-2 RNA detection compared to patients with mild or moderate disease. Severely immunocompromised patients (e.g., medical treatment with immunosuppressive drugs, bone marrow or solid organ transplant recipients, inherited immunodeficiency, poorly controlled HIV) may also have longer periods of SARS-CoV-2 RNA detection and prolonged shedding of infectious recovery. These groups may be contagious for longer than others. In addition, placing a patient in a setting where they will have close contact with individuals at risk for severe disease warrants a conservative approach.
Hence, a test-based strategy is preferred for discontinuation of transmission-based precautions for patients who are
Hospitalized or Severely immunocompromised or Being transferred to a long-term care or assisted living facility If testing is not readily available, facilities should use the non-test- based strategy for discontinuation of Transmission-Based Precautions or extend the period of isolation beyond the non-test-based-strategy duration, on a case by case basis in consultation with local and state public health authorities.
Discontinuation of empiric transmission-based precautions for patients suspected of having COVID-19: The decision to discontinue empiric Transmission-Based Precautions by excluding the diagnosis of COVID-19 for a suspected COVID-19 patient can be made based upon having negative results from at least one FDA Emergency Use Authorized COVID-19 molecular assay for detection of SARS-CoV-2.
If a higher level of clinical suspicion for COVID-19 exists, consider maintaining Transmission-Based Precautions and performing a second test for SARS-CoV-2. If a patient suspected of having COVID-19 is never tested, the decision to discontinue Transmission-Based Precautions can be made based upon using the non-test-based strategy described above. Ultimately, clinical judgement and suspicion of SARS-CoV-2 infection determines whether to continue or discontinue empiric Transmission-Based Precautions.
Disposition of Patients with COVID-19: Patients can be discharged from the healthcare facility whenever clinically indicated.
If discharged to home:
Isolation should be maintained at home if the patient returns home before discontinuation of Transmission-Based Precautions. The decision to send the patient home should be made in consultation with the patient’s clinical care team and local or state public health departments. It should include considerations of the home’s suitability for and patient’s ability to adhere to home isolation recommendations. Guidance on implementing home care of persons who do not require hospitalization and the discontinuation of home isolation for persons with COVID-19 is available. If discharged to a long-term care or assisted living facility, AND
Transmission-Based Precautions are still required, they should go to a facility with an ability to adhere to infection prevention and control recommendations for the care of COVID-19 patients. Preferably, the patient would be placed in a location designated to care for COVID-19 residents. Transmission-Based Precautions have been discontinued, but the patient has persistent symptoms from COVID-19 (e.g., persistent cough), they should be placed in a single room, be restricted to their room, and wear a facemask during care activities until all symptoms are completely resolved or until 14 days after illness onset, whichever is longer. Transmission-Based Precautions have been discontinued and the patient’s symptoms have resolved, they do not require further restrictions, based upon their history of COVID-19.
【 在 dime (dime) 的大作中提到: 】 : Discontinuation of transmission-based precautions for patients with COVID-19: : The decision to discontinue Transmission-Based Precautions should be made : using a test-based strategy or a non-test-based strategy (i.e., time-since- : illness-onset and time-since-recovery strategy). Meeting criteria for : discontinuation of Transmission-Based Precautions is not a prerequisite for : discharge. : Test-based strategy. : Resolution of fever without the use of fever-reducing medications and : Improvement in respiratory symptoms (e.g., cough, shortness of breath), and : Negative results of an FDA Emergency Use Authorized COVID-19 molecular assay : ...................
全美人口排名：
California (Population: 39,747,267)
Texas (Population: 29,087,070)
Florida (Population: 21,646,155)
New York (Population: 19,491,339)
Pennsylvania (Population: 12,813,969)
Illinois (Population: 12,700,381)
Ohio (Population: 11,718,568)
Georgia (Population: 10,627,767)
North Carolina (Population: 10,497,741)
Michigan (Population: 10,020,472)
看看德州的治愈率。 shithole也非shithole一眼明了：
德州测的数字全国第四，比很多shithole的40%阳性率的州测得还多。
德州阳性率10%
傻逼才说德州医疗滥吧。
德州医疗很厉害啊，西南医学中心啥的
测的人数比例还不如佛罗里达。
德州尼玛主要是住的人太稀，气候又干热。
【 在 dime (dime) 的大作中提到: 】
: 全美人口排名：
: California (Population: 39,747,267)
: Texas (Population: 29,087,070)
: Florida (Population: 21,646,155)
: New York (Population: 19,491,339)
: Pennsylvania (Population: 12,813,969)
: Illinois (Population: 12,700,381)
: Ohio (Population: 11,718,568)
: Georgia (Population: 10,627,767)
: North Carolina (Population: 10,497,741)
: ...................
难道不知道德州医学中心是世界上最大的医学中心吗？
前两天看到德州有个护士说进重症监护的，都死了
本人在德州住过，德州医疗不差，但也不能证明德州医疗好。
加州， 40万平方公里， 4千万人口；
德州， 70万平方公里， 3千万人口；
人口密度： 德州是加州的43%。
我觉得以下因素很重要：
天气燥热，三月份经常80 或90 度以上。
人口密度明显低于加州。
测试少， 人均甚至低于AZ。
德州医疗好是个笑话。
属实
【 在 Register9876 (Register9876) 的大作中提到: 】
: 本人在德州住过，德州医疗不差，但也不能证明德州医疗好。
: 加州， 40万平方公里， 4千万人口；
: 德州， 70万平方公里， 3千万人口；
: 人口密度： 德州是加州的43%。
: 我觉得以下因素很重要：
: 天气燥热，三月份经常80 或90 度以上。
: 人口密度明显低于加州。
: 测试少， 人均甚至低于AZ。
病毒从东向西传播
纽约州爆了，因为纽约州里欧洲最近，而且欧洲回来的人最多
其他地方很快也不乐观了，病毒正在往西部移动
扯这么多
先说清楚德州的治愈标准是啥？
【 在 dime (dime) 的大作中提到: 】
: 全美人口排名：
: California (Population: 39,747,267)
: Texas (Population: 29,087,070)
: Florida (Population: 21,646,155)
: New York (Population: 19,491,339)
: Pennsylvania (Population: 12,813,969)
: Illinois (Population: 12,700,381)
: Ohio (Population: 11,718,568)
: Georgia (Population: 10,627,767)
: North Carolina (Population: 10,497,741)
: ...................
Discontinuation of transmission-based precautions for patients with COVID-19:
The decision to discontinue Transmission-Based Precautions should be made
using a test-based strategy or a non-test-based strategy (i.e., time-since-
illness-onset and time-since-recovery strategy). Meeting criteria for
discontinuation of Transmission-Based Precautions is not a prerequisite for discharge.
Test-based strategy.
Resolution of fever without the use of fever-reducing medications and
Improvement in respiratory symptoms (e.g., cough, shortness of breath), and
Negative results of an FDA Emergency Use Authorized COVID-19 molecular assay for detection of SARS-CoV-2 RNA from at least two consecutive
nasopharyngeal swab specimens collected ≥24 hours apart (total of two
negative specimens) [1]. See Interim Guidelines for Collecting, Handling,
and Testing Clinical Specimens for 2019 Novel Coronavirus (2019-nCoV).
Non-test-based strategy.
At least 3 days (72 hours) have passed since recovery defined as resolution of fever without the use of fever-reducing medications and improvement in
respiratory symptoms (e.g., cough, shortness of breath); and,
At least 7 days have passed since symptoms first appeared
When a Testing-Based Strategy is Preferred
Hospitalized patients may have longer periods of SARS-CoV-2 RNA detection
compared to patients with mild or moderate disease. Severely
immunocompromised patients (e.g., medical treatment with immunosuppressive
drugs, bone marrow or solid organ transplant recipients, inherited
immunodeficiency, poorly controlled HIV) may also have longer periods of
SARS-CoV-2 RNA detection and prolonged shedding of infectious recovery.
These groups may be contagious for longer than others. In addition, placing a patient in a setting where they will have close contact with individuals at risk for severe disease warrants a conservative approach.
Hence, a test-based strategy is preferred for discontinuation of
transmission-based precautions for patients who are
Hospitalized or
Severely immunocompromised or
Being transferred to a long-term care or assisted living facility
If testing is not readily available, facilities should use the non-test-
based strategy for discontinuation of Transmission-Based Precautions or
extend the period of isolation beyond the non-test-based-strategy duration, on a case by case basis in consultation with local and state public health
authorities.
Discontinuation of empiric transmission-based precautions for patients
suspected of having COVID-19:
The decision to discontinue empiric Transmission-Based Precautions by
excluding the diagnosis of COVID-19 for a suspected COVID-19 patient can be made based upon having negative results from at least one FDA Emergency Use Authorized COVID-19 molecular assay for detection of SARS-CoV-2.
If a higher level of clinical suspicion for COVID-19 exists, consider
maintaining Transmission-Based Precautions and performing a second test for SARS-CoV-2.
If a patient suspected of having COVID-19 is never tested, the decision to
discontinue Transmission-Based Precautions can be made based upon using the non-test-based strategy described above.
Ultimately, clinical judgement and suspicion of SARS-CoV-2 infection
determines whether to continue or discontinue empiric Transmission-Based
Precautions.
Disposition of Patients with COVID-19:
Patients can be discharged from the healthcare facility whenever clinically indicated.
If discharged to home:
Isolation should be maintained at home if the patient returns home before
discontinuation of Transmission-Based Precautions. The decision to send the patient home should be made in consultation with the patient’s clinical
care team and local or state public health departments. It should include
considerations of the home’s suitability for and patient’s ability to
adhere to home isolation recommendations. Guidance on implementing home care of persons who do not require hospitalization and the discontinuation of
home isolation for persons with COVID-19 is available.
If discharged to a long-term care or assisted living facility, AND
Transmission-Based Precautions are still required, they should go to a
facility with an ability to adhere to infection prevention and control
recommendations for the care of COVID-19 patients. Preferably, the patient
would be placed in a location designated to care for COVID-19 residents.
Transmission-Based Precautions have been discontinued, but the patient has
persistent symptoms from COVID-19 (e.g., persistent cough), they should be
placed in a single room, be restricted to their room, and wear a facemask
during care activities until all symptoms are completely resolved or until
14 days after illness onset, whichever is longer.
Transmission-Based Precautions have been discontinued and the patient’s
symptoms have resolved, they do not require further restrictions, based upon their history of COVID-19.
【 在 wljyx (nescaf) 的大作中提到: 】
: 扯这么多
: 先说清楚德州的治愈标准是啥？
病毒自己的GPS搞得？一定要从东往西传？
哦不对啊，最先的列子是在西雅图，西海岸啊
加州也比纽约现有病例
德州首例和纽约基本同时
【 在 keyrock (不高兴) 的大作中提到: 】
: 病毒从东向西传播
: 纽约州爆了，因为纽约州里欧洲最近，而且欧洲回来的人最多
: 其他地方很快也不乐观了，病毒正在往西部移动
美国很大程度上被Trump 耽误了， ”大号流感“， “一切尽在掌控中”。从1/23 第
一例（WA State） 到三月中，错过最佳防疫时机，没有抗疫准备。先是极其乐观，后
是跌落谷底（死亡10万 到 25 万），最后死亡小于这个预估，就会说是他的措施得当
， 减轻了死亡。
NY 则被只知道与Trump 对着干的州长Cuomo 害了。 天天上电视，要这要那，只会作秀， 却得到支持率高。这也是民主的一个付产品， 很大程度上，选上一批玩弄选举的人。
人无完人， 我中国的亲属嘱咐我买口罩， 买消毒剂， 买粮食， 我口头答应，啥也没作，最后口罩从中国寄过来，比我当时从Amazon买贵数倍。消毒剂买不到， 米 和面
也是去了数次才买了三个星期的库存（可我把早期的机会留給了别人）。
【 在 keyrock (不高兴) 的大作中提到: 】
: 病毒从东向西传播
: 纽约州爆了，因为纽约州里欧洲最近，而且欧洲回来的人最多
: 其他地方很快也不乐观了，病毒正在往西部移动
别想当然了，飞机这玩意，不是离得近就多。
西海岸的加州从欧洲直达飞机一点不少，光一个三番就占了扭腰的一半了。再加上洛杉矶，圣迭戈以及一些小机场，最后弄不好比扭腰还多
【 在 keyrock (不高兴) 的大作中提到: 】
: 病毒从东向西传播
: 纽约州爆了，因为纽约州里欧洲最近，而且欧洲回来的人最多
: 其他地方很快也不乐观了，病毒正在往西部移动
别鸡巴搞笑了
你是fake news拉的全吞了才有这结论
早期大号流感是cdc的专家结论，川普复述了一遍而已
川普各种措施都是根据实际情况制定的，非常到位，除了断航欧洲晚了点，其他都非常及时
美国的问题明显是扭腰等深蓝shithole，民猪党的人渣搞出来的
去掉这些深蓝shithole，美国感染数量也就现在几分之一不到
【 在 Register9876 (Register9876) 的大作中提到: 】
: 美国很大程度上被Trump 耽误了， ”大号流感“， “一切尽在掌控中”。从1/23 第
: 一例（WA State） 到三月中，错过最佳防疫时机，没有抗疫准备。先是极其乐观，后
: 是跌落谷底（死亡10万 到 25 万），最后死亡小于这个预估，就会说是他的措施得当
: ， 减轻了死亡。
: NY 则被只知道与Trump 对着干的州长Cuomo 害了。 天天上电视，要这要那，只会作秀
: ， 却得到支持率高。这也是民主的一个付产品， 很大程度上，选上一批玩弄选举的人。
: 人无完人， 我中国的亲属嘱咐我买口罩， 买消毒剂， 买粮食， 我口头答应，啥也没
: 作，最后口罩从中国寄过来，比我当时从Amazon买贵数倍。消毒剂买不到， 米 和面
: 也是去了数次才买了三个星期的库存（可我把早期的机会留給了别人）。
和MN比比！
【 在 dime (dime) 的大作中提到: 】
: 全美人口排名：
: California (Population: 39,747,267)
: Texas (Population: 29,087,070)
: Florida (Population: 21,646,155)
: New York (Population: 19,491,339)
: Pennsylvania (Population: 12,813,969)
: Illinois (Population: 12,700,381)
: Ohio (Population: 11,718,568)
: Georgia (Population: 10,627,767)
: North Carolina (Population: 10,497,741)
: ...................
你贴了一大坨，是统计recovered的标准吗？
Recovered 需要核酸检测阴性吗？几次阴性？
【 在 dime (dime) 的大作中提到: 】
: Discontinuation of transmission-based precautions for patients with COVID-19:
: The decision to discontinue Transmission-Based Precautions should be made : using a test-based strategy or a non-test-based strategy (i.e., time-since-
: illness-onset and time-since-recovery strategy). Meeting criteria for
: discontinuation of Transmission-Based Precautions is not a prerequisite
for
: discharge.
: Test-based strategy.
: Resolution of fever without the use of fever-reducing medications and
: Improvement in respiratory symptoms (e.g., cough, shortness of breath),
and
: Negative results of an FDA Emergency Use Authorized COVID-19 molecular
assay
: ...................
禁EU航班那个春假周末，成千上万得旅客和带毒者堵在DFW入关口4-8小时，充分交叉感染后回家。